Peptide‐Driven Proton Sponge Nano‐Assembly for Imaging and Triggering Lysosome‐Regulated Immunogenic Cancer Cell Death
- 27 February 2024
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 36 (19) , e2307679
Abstract
Triggering lysosome‐regulated immunogenic cell death (ICD, e.g., pyroptosis and necroptosis) with nanomedicines is an emerging approach for turning an “immune‐cold” tumor “hot”—a key challenge faced by cancer immunotherapies. Proton sponge such as high‐molecular‐weight branched polyethylenimine (PEI) is excellent at rupturing lysosomes, but its therapeutic application is hindered by uncontrollable toxicity due to fixed charge density and poor understanding of resulted cell death mechanism. Here, a series of proton sponge nano‐assemblies (PSNAs) with self‐assembly controllable surface charge density and cell cytotoxicity are created. Such PSNAs are constructed via low‐molecular‐weight branched PEI covalently bound to self‐assembling peptides carrying tetraphenylethene pyridinium (PyTPE, an aggregation‐induced emission‐based luminogen). Assembly of PEI assisted by the self‐assembling peptide‐PyTPE leads to enhanced surface positive charges and cell cytotoxicity of PSNA. The self‐assembly tendency of PSNAs is further optimized by tuning hydrophilic and hydrophobic components within the peptide, thus resulting in the PSNA with the highest fluorescence, positive surface charge density, cell uptake, and cancer cell cytotoxicity. Systematic cell death mechanistic studies reveal that the lysosome rupturing‐regulated pyroptosis and necroptosis are at least two causes of cell death. Tumor cells undergoing PSNA‐triggered ICD activate immune cells, suggesting the great potential of PSNAs to trigger anticancer immunity.Keywords
Funding Information
- National Institutes of Health (P30 NS047101, S10 OD023555, R01 CA253615, S10 OD023527, AI125103, DA046171, DA049524, R01AI154138)
- National Science Foundation (1845683, DMR‐2011924)
This publication has 48 references indexed in Scilit:
- Liposomes Under Shear: Structure, Dynamics, and Drug Delivery ApplicationsAdvanced NanoBiomed Research, 2023
- Peptide Amphiphile Mediated Co‐assembly for Nanoplasmonic SensingAngewandte Chemie International Edition, 2022
- Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OCAdvanced Science, 2022
- Supramolecular Self‐Assembly‐Facilitated Aggregation of Tumor‐Specific Transmembrane Receptors for Signaling Activation and Converting Immunologically Cold to Hot TumorsAdvanced Materials, 2021
- Targeting immunogenic cell death in cancerMolecular Oncology, 2020
- Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer TherapyAngewandte Chemie International Edition, 2020
- Targeting necroptosis in anticancer therapy: mechanisms and modulatorsActa Pharmaceutica Sinica B, 2020
- NaCl Nanoparticles as a Cancer TherapeuticAdvanced Materials, 2019
- A real-time, bioluminescent annexin V assay for the assessment of apoptosisApoptosis, 2018
- Biodegradable and Renal Clearable Inorganic NanoparticlesAdvanced Science, 2015